Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.8160
-0.0222 (-2.65%)
At close: Apr 14, 2026, 4:00 PM EDT
0.7960
-0.0200 (-2.45%)
Pre-market: Apr 15, 2026, 8:17 AM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $193.7 million as of April 15, 2026. Its market cap has increased by 763.62% in one year.
Market Cap
193.70M
Enterprise Value
188.59M
1-Year Change
763.62%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has increased from $101.63M to $193.70M, an increase of 90.59%. That is a compound annual growth rate of 9.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 193.70M | 16.04% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 238.44M |
| Arcturus Therapeutics Holdings | 237.62M |
| Eledon Pharmaceuticals | 235.50M |
| Camp4 Therapeutics | 233.12M |
| MediWound | 229.41M |
| MacroGenics | 228.80M |
| Context Therapeutics | 228.78M |
| ALX Oncology Holdings | 223.73M |